21 Feb Decentralized clinical trial models: Are they here to stay?

Nadina Jose, Rutgers University via The Association of Clinical Research Professionals (ACRP)

Decentralized clinical trial (DCT) elements enabled clinical research to continue during the pandemic, when physical attendance at healthcare facilities was often impossible. These relied on use of various innovative processes, systems, tools, and technologies by study participants and clinical research professionals alike – either onsite or offsite at centers such as pharmacies or even at the patient’s home.

“Aspects of DCTs have technically existed for as long as 15 years, but this buzzword has gained in popularity since the start of the COVID-19 pandemic,” notes Nadina Jose, MD, Assistant Professor in the School of Health Professions at Rutgers, The State University of New Jersey. “We’re hearing that DCTs are now the norm, yet questions remain about their sustainability and future applications.” Read more …